Norris Medicines Share Price

ABOUT Norris Medicines

• Industry Biotechnology & Drugs
• ISIN INE744C01029
• BSE Code 524414

Norris Medicines Limited is an India-based company, which is focused on the health care industry. The Company is engaged in the manufacturing and exporting medicines and injections. The Company’s product categories include antibiotic, anti-inflammatory and analgesic range, G. I. range, dermatological range, nutrition range, anti-malaria, anti-emetic, cough/cold range, dental range, diabetics and cardiac, and miscellaneous range. Its antibiotic products include Arizon-100, Arizon-250, Arizon-500, Cefan-dry syurp, and Cefan DT-50. Its G.I. products include Denzym Syrup, Denzym Oral Drop, Ezynor-20, Regus-DSR, Sucrinor and Rinotac. Its dermatological products include Clobec-G, Gabax, Morfit Plus, Novadin-M, Silwon-C and Tioderm. Its nutrition products include Cand XP, Cand Fort, Can D suspension and Hemfit Plus Syrup. It has two plants situated at GIDC, Ankleshwar, Gujarat. Both the plants of the Company are World Health Organization Good Manufacturing Practices (WHO GMP) approved.

MANAGEMENT

• Iqubal Patel Chief Financial Officer
• Priyanka Lohiya Company Secretary and Compliance Officer
• Vimal Shah Managing Director, Executive Director